ECSP034682A - ANCIGONISTS OF RECEIVERS OF EXCITATORY AMINO ACIDS - Google Patents
ANCIGONISTS OF RECEIVERS OF EXCITATORY AMINO ACIDSInfo
- Publication number
- ECSP034682A ECSP034682A EC2003004682A ECSP034682A ECSP034682A EC SP034682 A ECSP034682 A EC SP034682A EC 2003004682 A EC2003004682 A EC 2003004682A EC SP034682 A ECSP034682 A EC SP034682A EC SP034682 A ECSP034682 A EC SP034682A
- Authority
- EC
- Ecuador
- Prior art keywords
- ancigonists
- receivers
- amino acids
- excitatory amino
- salt
- Prior art date
Links
- 239000003257 excitatory amino acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 4
- XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 abstract 2
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una sal farmacéutica mente aceptable de un compuesto de fórmula: (gráfico) o un pro fármaco del mismo en la que la sal farmaceúticamente aceptable se selecciona del grupo constituido por la sal del ácido D-( -)-mandélico o la sal del ácido 1, 5-naftalenodisulfónico.A pharmaceutically acceptable salt of a compound of the formula: (graph) or a pro-drug thereof in which the pharmaceutically acceptable salt is selected from the group consisting of the salt of D- (-) - mandelic acid or the salt of acid 1 , 5-naphthalenedisulfonic acid.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034682A true ECSP034682A (en) | 2003-08-29 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2003004682A ECSP034682A (en) | 2001-01-05 | 2003-07-03 | ANCIGONISTS OF RECEIVERS OF EXCITATORY AMINO ACIDS |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (en) |
| JP (1) | JP2004520335A (en) |
| KR (1) | KR20030066797A (en) |
| CN (1) | CN1484642A (en) |
| AR (1) | AR035679A1 (en) |
| BR (1) | BR0116672A (en) |
| CA (1) | CA2431545A1 (en) |
| CZ (1) | CZ20031856A3 (en) |
| DZ (1) | DZ3460A1 (en) |
| EA (1) | EA200300770A1 (en) |
| EC (1) | ECSP034682A (en) |
| HR (1) | HRP20030544A2 (en) |
| HU (1) | HUP0302528A2 (en) |
| IL (1) | IL156138A0 (en) |
| MX (1) | MXPA03005981A (en) |
| NO (1) | NO20032973L (en) |
| NZ (1) | NZ525821A (en) |
| PE (1) | PE20020792A1 (en) |
| PL (1) | PL361934A1 (en) |
| SK (1) | SK8242003A3 (en) |
| TW (1) | TW591023B (en) |
| WO (1) | WO2002053561A1 (en) |
| ZA (1) | ZA200304311B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| SK11812000A3 (en) * | 1998-02-06 | 2001-08-06 | Smithkline Beecham Plc | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| PT1200073E (en) * | 1999-07-06 | 2007-03-30 | Lilly Co Eli | Selective iglur 5? receptor antagonists for the treatment of migraine |
-
2001
- 2001-12-20 EA EA200300770A patent/EA200300770A1/en unknown
- 2001-12-20 PL PL01361934A patent/PL361934A1/en not_active Application Discontinuation
- 2001-12-20 IL IL15613801A patent/IL156138A0/en unknown
- 2001-12-20 CN CNA018217508A patent/CN1484642A/en active Pending
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/en active Pending
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Ceased
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/en unknown
- 2001-12-20 HR HR20030544A patent/HRP20030544A2/en not_active Application Discontinuation
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/en active
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/en not_active IP Right Cessation
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/en unknown
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/en unknown
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/en not_active Withdrawn
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/en unknown
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
-
2002
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/en not_active Application Discontinuation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/en not_active Application Discontinuation
- 2002-01-04 TW TW091100071A patent/TW591023B/en not_active IP Right Cessation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973L/en not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DZ3460A1 (en) | 2002-07-11 |
| EA200300770A1 (en) | 2003-10-30 |
| MXPA03005981A (en) | 2003-09-10 |
| TW591023B (en) | 2004-06-11 |
| ZA200304311B (en) | 2004-09-02 |
| PL361934A1 (en) | 2004-10-18 |
| HRP20030544A2 (en) | 2004-08-31 |
| NO20032973D0 (en) | 2003-06-27 |
| HUP0302528A2 (en) | 2003-11-28 |
| JP2004520335A (en) | 2004-07-08 |
| CZ20031856A3 (en) | 2003-09-17 |
| PE20020792A1 (en) | 2002-09-06 |
| CN1484642A (en) | 2004-03-24 |
| BR0116672A (en) | 2003-09-23 |
| WO2002053561A1 (en) | 2002-07-11 |
| NZ525821A (en) | 2004-07-30 |
| SK8242003A3 (en) | 2004-01-08 |
| AR035679A1 (en) | 2004-06-23 |
| EP1351955A1 (en) | 2003-10-15 |
| NO20032973L (en) | 2003-06-27 |
| CA2431545A1 (en) | 2002-07-11 |
| KR20030066797A (en) | 2003-08-09 |
| IL156138A0 (en) | 2003-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5271657A1 (en) | DERIVATIVES OF AZAINDOL | |
| HRP20020428B1 (en) | Bicyclic amino acids as pharmaceutical agents | |
| CO5580776A2 (en) | STABLE PHARMACEUTICAL FORMULATION IN SOLUTION OF OXALIPLATIN | |
| EA200300065A1 (en) | OXIDIZED COMPLEX ETHERS OF 4-IODPHENYLAMINOBENE HYDROXAMIC ACIDS | |
| BR9900443A (en) | Acrylic aryl acid esters. | |
| BR0107837A (en) | Process for solubilization of glucagon-like peptide 1 compounds | |
| DE69507614D1 (en) | 3-AMINO-2-OXO-PIPERIDINESSIGIC ACID DERIVATIVES CONTAINING A COMPATIBLE ARGININE WITH ENZYMINHIBITORIC EFFECT | |
| EP1392293A4 (en) | PROCESS FOR THE TREATMENT OF TUMORS BASED ON NORDIHYDROGUAIARETIC ACID DERIVATIVES | |
| CY1120408T1 (en) | IMPROVED PHARMACEUTICAL FORMS | |
| MY133507A (en) | New peroxy-carboxylic acid and aqueous compositions thereof | |
| BR0002073A (en) | Process for the preparation of a chiral compound | |
| ATE322487T1 (en) | HYDROXAMIC ACID DERIVATIVES | |
| CO5280222A1 (en) | PHARMACEUTICAL COMPOSITION THAT PEMETREXED INCLUDES | |
| BR9913670B1 (en) | process for the preparation of a salt of an aliphatic carboxylic acid compound. | |
| CO5720995A2 (en) | NEW COMPOUND | |
| ES2422081T3 (en) | Peptide Ser-Ser-Ser-Arg and its medicinal uses | |
| AR021232A1 (en) | METIONIN PREPARATION PROCEDURE. | |
| DE60115954D1 (en) | PROCESS FOR THE PREPARATION OF GABAPENTIN | |
| DE69327890D1 (en) | Process for the preparation of 2- (un) substituted 4-alkylimidazoles | |
| AR030630A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EP1306367A4 (en) | SULFONIC ACID DERIVATIVES OF HYDROXAMIC ACIDS AND THEIR USE AS MEDICAL PRODUCTS | |
| ECSP034682A (en) | ANCIGONISTS OF RECEIVERS OF EXCITATORY AMINO ACIDS | |
| WO2002026732A1 (en) | Benzodiazepine derivative | |
| SE9902364D0 (en) | New process | |
| BR0110549A (en) | Process for the preparation of alkaline earth metal salts of d-pantothenic acid |